Physician profile
Oscar E Andrade
NPI 1275685521
$2,967.19
in general payments reported to CMS, 2019-2025
29 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $340 · 2021: $503 · 2022: $511 · 2023: $477 · 2024: $477 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $511.49 | 2019-2025 | Jardiance, Stiolto Respimat |
| Abbvie INC. | $410.75 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Novo Nordisk INC | $369.19 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $282.48 | 2020-2024 | Jardiance, Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $131.54 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $131.19 | 2019-2024 | Breztri, Airsupra |
| Pfizer INC. | $126.95 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $119.44 | 2019-2022 | |
| Organogenesis INC. | $107.67 | 2022-2025 | Via Matrix, Puraply Wound Matrix |
| Allergan, INC. | $99.64 | 2020-2021 | |
| Mimedx Group, INC. | $77.92 | 2024-2025 | |
| Amgen INC. | $75.83 | 2024 | Otezla, Repatha |
| Lucid Diagnostics INC. | $61.94 | 2022-2024 | |
| Organon LLC | $52.72 | 2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $45.29 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $44.97 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $44.42 | 2020-2024 | Pediarix, Rotarix, Bexsero |
| Edwards Lifesciences Corporation | $42.37 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Tactile Systems Technology INC | $38.99 | 2025 | Flexitouch Plus, Nimbl |
| Takeda Pharmaceuticals U.S.A., INC. | $32.86 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.48 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $26.93 | 2019-2021 | |
| Dexcom, INC. | $17.49 | 2025 | Dexcom G6 Transmitter |
| Eisai INC. | $15.95 | 2021 | |
| Grifols USA, LLC | $14.56 | 2019 | |
| Inspire Medical Systems, INC. | $14.38 | 2025 | Inspire |
| Electromed, INC. | $13.98 | 2021 | |
| Urgo Medical North America, LLC | $13.54 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Phadia US INC. | $13.23 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Andrade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.